59892-40-9

Usage

Uses

Used in Pharmaceutical Industry:
4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one is used as a synthetic intermediate for the development of novel pharmaceutical compounds. Its unique structure allows for the creation of new drugs with potential therapeutic applications, making it a valuable asset in the pharmaceutical industry.
Used in Chemical Research:
As a useful synthetic intermediate, 4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one is also employed in chemical research for the synthesis of various complex molecules. Its versatility in chemical reactions enables researchers to explore new avenues in chemical synthesis and develop innovative compounds with diverse applications.
Used in Material Science:
The solid-state nature of 4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one makes it a candidate for use in material science, where it can be utilized in the development of new materials with specific properties. Its unique chemical structure may contribute to the creation of materials with enhanced performance characteristics, such as improved stability or reactivity.

InChI:InChI=1/C10H12N4O5/c15-3-5-7(17)8(18)10(19-5)14-6(16)2-1-4-9(14)12-13-11-4/h1-2,5,7-8,10,15,17-18H,3H2,(H,11,12,13)/t5-,7+,8?,10-/m1/s1

Upstream product

• 59892-36-3 1-(β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 
• 14215-97-5 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose 
• 6974-32-9 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose 
• 5418-51-9 5-nitro-2-hydroxypyridine 
• 656808-98-9 5-nitro-2-trimethylsilanyloxy-pyridine 
• 59892-37-4 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 

Relevant academic research and scientific papers

Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one and its 3′-deoxysugar analogue as potential anti-hepatitis C virus agents

We recently discovered a novel compound, identified as N 3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b] pyridinin-5-one, with anti-hepatitis C virus (HCV) activity in vitro. The structure was confirmed by chemical synthesis from 2-hydroxy

Synthesis and structure-activity relationships of novel anti-hepatitis C agents: N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4, 5-b]pyridin-5-one derivatives

Several 6- and 7-monosubstituted N3,5′-cyclo-4-(β-D- ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives as well as the 5-thiono analogue were synthesized, providing structure - anti-hepatitis C virus (HCV) activity relationships for th

Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity

A novel anti-hepatitis C virus (HCV) agent, N3,5′-cyclo-4- (β-D-ribofuranosyl)-vic-triazolo(4,5-b]pyridinin-5-one, was identified, and the structure was confirmed by chemical synthesis from 2-hydroxy-5- nitropyridine.